Toprol-xl and Meningitis - a phase IV clinical study of FDA data

Summary:

Meningitis is reported as a side effect among people who take Toprol-xl (metoprolol succinate), especially for people who are female, 60+ old, also take Neurontin, and have Dyspnea.

The phase IV clinical study analyzes which people have Meningitis when taking Toprol-xl. It is created by eHealthMe based on reports of 38,273 people who have side effects when taking Toprol-xl from the FDA, and is updated regularly.

What is Toprol-xl?

Toprol-xl has active ingredients of metoprolol succinate. It is often used in high blood pressure. eHealthMe is studying from 40,636 Toprol-xl users. Check the latest studies of Toprol-xl.

What is Meningitis?

Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges) is found to be associated with 650 drugs and 880 conditions by eHealthMe. Check the latest studies of Meningitis.

On Jul, 14, 2026

38,273 people reported to have side effects when taking Toprol-xl.
Among them, 15 people (0.04%) have Meningitis.

Among these 15 people:

What is the gender of people who have Meningitis when taking Toprol-xl? *

female: 73.33 %
male: 26.67 %

What is the age of people who have Meningitis when taking Toprol-xl? *

What are other drugs people take besides Toprol-xl? *

What are other side effects people have besides Meningitis? *

Nausea And Vomiting: 4 people, 26.67%
Weakness: 4 people, 26.67%
Nausea (feeling of having an urge to vomit): 4 people, 26.67%
Hyperhidrosis (abnormally increased sweating): 3 people, 20.00%
Overdose: 3 people, 20.00%
Photosensitivity Reaction: 3 people, 20.00%
Muscle Spasms (muscle contraction): 3 people, 20.00%
Meniscus Lesion (lesion of a crescent-shaped piece of cartilage between the femur and the tibia): 3 people, 20.00%
Csf Glucose Abnormal: 3 people, 20.00%
Infection: 3 people, 20.00%

What are the existing conditions these people have? *

Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 3 people, 20.00%
Dyspnea (difficult or laboured breathing): 3 people, 20.00%
Pain: 2 people, 13.33%
Neuropathy Peripheral (surface nerve damage): 2 people, 13.33%
Sleep Disorder: 1 person, 6.67%
Sinus Disorder (disease of sinus): 1 person, 6.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 6.67%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 6.67%
Memory Loss: 1 person, 6.67%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Toprol-xl and have Meningitis?

- Check whether Meningitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Toprol-xl:

Toprol-xl (40,636 reports)

Meningitis treatments and more:

Meningitis (9,443 reports)

Browse all side effects of Toprol-xl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Meningitis:

Meningitis (650 drugs)

Browse all the conditions that are associated with Meningitis:

Meningitis (880 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metoprolol succinate (the active ingredients of Toprol-xl) and Toprol-xl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.